期刊文献+

自体负载肿瘤抗原树突状细胞治疗大鼠甲状腺癌

Immunotherapeutic effects of auto dendritic cells loaded with tumor lysates on rat transitional thyroid carcinoma
原文传递
导出
摘要 目的 观察自体负载肿瘤抗原树突状细胞(DC)对大鼠甲状腺癌的治疗作用.方法 建立Wistar荷瘤大鼠动物模型,随机分为治疗组和对照组,治疗组静脉输入负载肿瘤抗原DC、对照组输入生理盐水,检测分析2组血清中自细胞介素(IL)-12、IL-8表达水平,以及瘤重、瘤体体积及大鼠存活.结果 治疗组与对照组瘤重、瘤体体积、存活期、IL-12及IL-8表达水平分别为:(3.56±0.79)g比(4.97±0.56)g、(3.98±0.84)cm^3比(5.06±0.58)cm^3、(36.0±3.0)d比(28.0±3.2)d、(368.9±21.7)ng/L比(227.7±13.4)ng/L和(218.9±19.3)ng/L比(371.2±24.1)ng/L(P值分别〈0.01、〈0.01、〈0.05、〈0.01、〈0.01).结论 自体负载肿瘤抗原DC对甲状腺癌具有较好的抑瘤效应,可延长荷瘤鼠的生存期. Objective To investigate the immunotherapeutic effects of auto dendritic cells (DC) loaded with tumor lysates on rat transitional thyroid carcinoma. Methods After the thyroid tumor models in Wistar rats were successfully established, all rats were divided randomly into the treatment group and the control group. DC loaded with tumor lysates were injected into the tail vein of the rats in the treatment group, and the rats in control group, normal saline was injected into the tail vein. The levels of interleukin (IL)-12 and IL-8 in serum, the tumor weight and volume, and the life span of the rats were measured. Results The average tumor weight and volume, the life span, the levels of IL-12 and IL-8 in the treatment group and the control group were respectively (3. 56±0. 79) g vs (4. 97±0. 56) g, (3. 98±0. 84) cm^3 vs (5.06±0.58) cm^3, (36.0±3.0) days vs (28.0±3.2) days, (368.9±21.7) ng/L vs (227.7±13.4) ng/L, (218.9±19.3) ng/L vs (371.2±24. 1) ng/L. P values 〈0.01, 〈0.01, 〈0.05,〈0.01, 〈0.01, respectively. Conclusion Auto DC loaded with tumor lysates can inhibit tumor growth and prolong the survival time of Wistar rats with thyroid carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第6期722-724,共3页 Chinese Journal of Experimental Surgery
关键词 肿瘤生物治疗 甲状腺癌 树突状细胞 Tumor biotherapy Thyroid carcinoma Dendritic cells
  • 相关文献

参考文献11

  • 1Di Nicola M,Zappasodi R,Carlo-Stella C,et al.Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease:a pilot study.Blood,2009,113:18-27.
  • 2Bercovici N,Haicheur N,Massicartl S,et al.Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.J Immunother,2008,31:101-112.
  • 3冯剑锷,孙宗全,史嘉玮,高开柱.低剂量粒巨噬细胞集落刺激因子培养小鼠骨髓源性未成熟树突状细胞的实验研究[J].中华实验外科杂志,2006,23(2):221-223. 被引量:13
  • 4陈炬,华平,张强,彭江洲,黎亮,杨艳旗.肺癌抗原负载的树突细胞体外诱导细胞毒性T淋巴细胞的杀瘤作用[J].中华实验外科杂志,2006,23(11):1337-1339. 被引量:9
  • 5Hatfield P,Merrick AE,West E,et al.Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.J Immunother,2008,31:620-632.
  • 6关心,冷希圣,彭吉润,魏玉华,王卉,袁兰.肝癌融合细胞疫苗的快速制备[J].中华实验外科杂志,2007,24(12):1520-1521. 被引量:1
  • 7Alban G,Olivier T,Francoise BT,et al.In vitro antitumor lymphocyte generation using dendritic cells and innate immunity mechanisms as tumor cell treatments.Anticancer Res,2007,27:2385-2392.
  • 8Masaru U.Chie KS,Go H,et al.Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and bacillus calmetteguerin cell wall skeleton stimulation.Clin Cancer Res,2006,12:7465-7475.
  • 9Bachleitner-Hofmann T,Friedl J,Hassler M,et al.Pilot trial of autologous dendritic cells loaded with tumor lysate (s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma.Oncol Rep,2009,21:1585-1592.
  • 10Palmer DH.Midgley RS,Mirza N,et al.A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.Hepatology,2009,49:124-132.

二级参考文献23

  • 1彭宝岗,梁力建,谢斌辉,陈祖兵,何强.转染肿瘤mRNA的树突状细胞疫苗诱导抗肝癌免疫研究[J].中华实验外科杂志,2005,22(4):432-434. 被引量:11
  • 2盛立霞,邱国强,谢晓宝,顾伟英,王志林,吴浩清.两种白血病细胞抗原负载DC的体外诱导特异性CTL应答的比较[J].细胞与分子免疫学杂志,2005,21(2):205-209. 被引量:12
  • 3唐顺,郭卫,郭义,曲华毅,李大森.树突状细胞与尤文肉瘤细胞融合诱导抗肿瘤免疫应答的体外研究[J].中华外科杂志,2005,43(12):803-806. 被引量:3
  • 4Lutz MB,Suri RM,Niimi M Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.Eur J Immunol,2000,30:1813-1822.
  • 5Lutz MB,Kukutsch N,Ogilvie AL An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.J Immunol Methods,1999,223:77-92.
  • 6Inaba K,Inaba M,Romani N Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.J Exp Med,1992,176:1693-1702.
  • 7Heufler C,Koch F,Stanzl U Interleukin-12 is produced by dendritic cells and mediates T helper 1 devdopment as well as interferon-gamma production by T helper 1 cells.Eur J Immunol,1996,26:659-668.
  • 8Steinbrink K,Wolff M,Jonuleit H Induction of tolerance by IL-10-treated dendritic cells.J Immunol,1997,159:4772-4780.
  • 9Bonham CA,Lu L,Banas RA TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigenpresenting cells for both naive and primed T cells.Transpl Immunol,1996,4:186-191.
  • 10Caux C,Massacrier C,Vanbervliet B Interleukin 10 inhibits T cell alloreac-tion induced by human dendritic cells.Int Immunol,1994,6:1177-1185.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部